| Product NDC: | 54868-4456 |
| Proprietary Name: | Tazorac |
| Non Proprietary Name: | Tazarotene |
| Active Ingredient(s): | 1 mg/g & nbsp; Tazarotene |
| Administration Route(s): | ORAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54868-4456 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020600 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101021 |
| Package NDC: | 54868-4456-0 |
| Package Description: | 1 TUBE in 1 CARTON (54868-4456-0) > 100 g in 1 TUBE |
| NDC Code | 54868-4456-0 |
| Proprietary Name | Tazorac |
| Package Description | 1 TUBE in 1 CARTON (54868-4456-0) > 100 g in 1 TUBE |
| Product NDC | 54868-4456 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tazarotene |
| Dosage Form Name | GEL |
| Route Name | ORAL |
| Start Marketing Date | 20101021 |
| Marketing Category Name | NDA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | TAZAROTENE |
| Strength Number | 1 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |